Phase I study of onapristone, a type I antiprogestin, in female patients with previously treated recurrent or metastatic progesterone receptor-expressing cancers
一项针对既往接受过治疗的复发性或转移性孕激素受体表达癌症女性患者的 I 期研究,评估了 I 型抗孕激素奥那普酮的疗效。
期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0204973
Cottu, Paul H; Bonneterre, Jacques; Varga, Andrea; Campone, Mario; Leary, Alexandra; Floquet, Anne; Berton-Rigaud, Dominique; Sablin, Marie-Paule; Lesoin, Anne; Rezai, Keyvan; Lokiec, François M; Lhomme, Catherine; Bosq, Jacques; Bexon, Alice S; Gilles, Erard M; Proniuk, Stefan; Dieras, Veronique; Jackson, David M; Zukiwski, Alexander; Italiano, Antoine